Description
Aprepitantisaninhibitorofthetachykinin/neurokinin1(NK1)receptorthatactsasanantiemeticoranti-nauseamedicine.Aprepitantalsoexhibitssomeanticancerchemotherapeuticandanti-angiogenicbenefitthroughitsinhibitionofNK1receptors,preventingbindingofsubstancePandinhibitingsubstanceP’sproliferativeandpro-angiogenicsignalingcascade.Thiscompoundmayalsodisplaysomeantidepressantactivity,althoughinvivoandclinicalresultshavebeenmixed.
References
MuñozM,Martinez-ArmestoJ,CoveñasR.NK-1receptorantagoNISTsasantitumordrugs:asurveyoftheliteraturefrom2000to2011.ExpertOpinTherPat.2012Jul;22(7):735-46.PMID:22697287.
MassaroAM,LenzKL.Aprepitant:anovelantiemeticforchemotherapy-inducednauseaandvomiting.AnnPharmacother.2005Jan;39(1):77-85.PMID:15562136.
KramerMS,CutlerN,FeighnerJ,etal.DistinctmechanismforantidepressantactivitybyblockadeofcentralsubstancePreceptors.Science.1998Sep11;281(5383):1640-5.PMID:9733503.